.alpha.-ARYL- OR ARALKYL-.alpha.(CYCLOALKYL-ALKYL)1H-AZOLE- 1-ETHANOLS
CA 1232278 A · Owner: Novartis Ag · Inventors: Schaub, Fritz
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
NOVEL .alpha.-ARYL- OR ARALKYL-.alpha.(CYCLOALKYL-ALKYL)1H-AZOLE-1-ETHANOLS Abstract of the Disclosure, The invention provides novel compounds of formula I I, wherein Y is CH or N, R1 is C1-5alkyl unsubstituted or substituted by halogen by, C1-5alkoxy, by phenyl-C1-3alkoxy, by phenoxy by C1-5alkyl-, thio, by phenyl-C1-3alkylthio or by phenylthio whereby, optional phenyl groups may be substituted by C1-5alkyl halogen, halogen substituted C1-5alkyl C1-5alkoxy or, halogen substituted C1-5alkoxy; or is C2-5alkenyl or C2-5alkinyl, unsubstituted or substituted by halogen;or is cycloalkyl, unsubstituted or substituted by C1-5alkyl;or is phenyl, unsubstituted or substituted by substituents selected …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Granted February 2, 1988. A Canadian patent filed before October 1, 1989 lasted 17 years from grant, so its term ended February 2, 2005.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.